The sphingoid base backbones of sphingolipids (sphingosines, sphinganines, 4-hydroxysphinganines and others) are highly bioactive species directly and-in most cases-as their metabolites, the N-acyl-sphingoid bases (ceramides) and sphingoid base 1-phosphates. The complexity of these compounds affords many opportunities to prepare synthetic analogs for studies of sphingolipid metabolism and the functions of the sphingoid bases and metabolites. Described in this review are methods for the preparation of libraries of sphingoid bases, including a series of 1-deoxy-analogs, as well as information about their metabolism and biological activities. Findings with these compounds have uncovered some of the complications of working with compounds that mimic a naturally occurring biomodulator-such as that they are sometimes metabolized by enzymes that handle the endogenous compounds and the products may have potent (and unexpected) biological activities. Through studying such compounds, there is now a greater understanding of the metabolism and mechanism(s) of action of naturally occurring sphingoid bases as well as of these analogs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s1043-6618(03)00054-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
SPTLC3 regulates plasma membrane sphingolipid composition to facilitate hepatic gluconeogenesis.
Cell Rep
December 2024
Department of Biochemistry, Virginia Commonwealth University, Richmond, VA 23298, USA. Electronic address:
SPTLC3, an inducible subunit of the serine palmitoyltransferase (SPT) complex, causes production of alternative sphingoid bases, including a 16-carbon dihydrosphingosine, whose biological function is only beginning to emerge. High-fat feeding induced SPTLC3 in the liver, prompting us to produce a liver-specific knockout mouse line. Following high-fat feeding, knockout mice showed decreased fasting blood glucose, and knockout primary hepatocytes showed suppressed glucose production, a core function of hepatocytes.
View Article and Find Full Text PDFElucidation and engineering of Sphingolipid biosynthesis pathway in Yarrowia lipolytica for enhanced production of human-type sphingoid bases and glucosylceramides.
Metab Eng
January 2025
Department of Life Science, Chung-Ang University, Seoul, 06974, South Korea. Electronic address:
Sphingolipids are vital membrane components in in mammalian cells, plants, and various microbes. We aimed to explore and exploit the sphingolipid biosynthesis pathways in an oleaginous and dimorphic yeast Yarrowia lipolytica by constructing and characterizing mutant strains with specific gene deletions and integrating exogenous genes to enhance the production of long-chain bases (LCBs) and glucosylceramides (GlcCers). To block the fungal/plant-specific phytosphingosine (PHS) pathway, we deleted the SUR2 gene encoding a sphinganine C4-hydroxylase, resulting in a remarkably elevated secretory production of dihydrosphingosine (DHS) and sphingosine (So) without acetylation.
View Article and Find Full Text PDFStructure Revision of Halisphingosine A via Total Synthesis and Bioactivity Studies.
Angew Chem Int Ed Engl
December 2024
Chemical Biology of Microbe-Host Interactions, Leibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll Institute (Leibniz-HKI), Beutenbergstraße 11a, 07745, Jena, Germany.
Sphingoid bases are important bioactive lipids found in a variety of organisms, serving as the backbone of sphingolipids, which regulate essential physiological processes. Here we describe the total synthesis and structure revision of halisphingosine A, a sphingoid base initially isolated from marine sponges. To address inconsistencies in the NMR interpretation of this natural product, we developed a synthetic route involving a late-stage enantioselective Henry reaction that allows access to multiple stereoisomers of the proposed halisphingosine A core structure.
View Article and Find Full Text PDFMultiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.
Neurobiol Dis
November 2024
Institute of Genetics and Biophysics "Adriano Buzzati-Traverso", National Research Council, Naples, Italy; IRCCS INM Neuromed, Pozzilli, IS, Italy. Electronic address:
Article Synopsis
- The study investigates the lipid and metabolite profiles in Parkinson's disease (PD) patients to uncover new pathways and potential biomarkers for early detection and treatment.* -
- It highlights significant differences in lipid profiles among three groups (No L-Dopa, L-Dopa, and DBS) with findings that show increases in specific lipid species, particularly with deep brain stimulation (DBS) treatment.* -
- The research also reveals dysregulation in amino acid metabolism, especially L-glutamic acid, suggesting that DBS may positively influence glutamate levels, offering insights for future PD diagnosis and therapies.*
The genes are important for growth in the presence of sphingosine by promoting sphingosine metabolism.
bioRxiv
September 2024
Department of Microbiology and Molecular Genetics, Larner College of Medicine, University of Vermont.
Sphingoid bases, including sphingosine, are important components of the antimicrobial barrier at epithelial surfaces where they can cause growth inhibition and killing of susceptible bacteria. is a common opportunistic pathogen that is less susceptible to sphingosine than many Gram-negative bacteria. Here, we determined that deletion of the operon reduced growth in the presence of sphingosine.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!